chr19-3491746-C-CGGTT
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001145165.2(DOHH):c.654_655insAACC(p.Glu219fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.001 in 1,511,436 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.00070 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 0 hom. )
Consequence
DOHH
NM_001145165.2 frameshift
NM_001145165.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.304
Genes affected
DOHH (HGNC:28662): (deoxyhypusine hydroxylase) This gene encodes a metalloenzyme that catalyzes the last step in the conversion of lysine to the unique amino acid hypusine in eukaryotic initiation factor 5A. The encoded protein hydroxylates deoxyhypusine to form hypusine in the mature eukaryotic initiation factor 5A protein. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-3491746-C-CGGTT is Pathogenic according to our data. Variant chr19-3491746-C-CGGTT is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1285602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOHH | NM_001145165.2 | c.654_655insAACC | p.Glu219fs | frameshift_variant | 5/5 | ENST00000427575.6 | NP_001138637.1 | |
DOHH | NM_031304.5 | c.654_655insAACC | p.Glu219fs | frameshift_variant | 5/5 | NP_112594.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOHH | ENST00000427575.6 | c.654_655insAACC | p.Glu219fs | frameshift_variant | 5/5 | 1 | NM_001145165.2 | ENSP00000398882.1 | ||
DOHH | ENST00000672935.1 | c.654_655insAACC | p.Glu219fs | frameshift_variant | 5/5 | ENSP00000500806.1 | ||||
DOHH | ENST00000673168.1 | n.447_448insAACC | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.000704 AC: 107AN: 151972Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
107
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000327 AC: 34AN: 104072Hom.: 0 AF XY: 0.000347 AC XY: 20AN XY: 57702
GnomAD3 exomes
AF:
AC:
34
AN:
104072
Hom.:
AF XY:
AC XY:
20
AN XY:
57702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00103 AC: 1405AN: 1359346Hom.: 0 Cov.: 32 AF XY: 0.00100 AC XY: 673AN XY: 669876
GnomAD4 exome
AF:
AC:
1405
AN:
1359346
Hom.:
Cov.:
32
AF XY:
AC XY:
673
AN XY:
669876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000704 AC: 107AN: 152090Hom.: 0 Cov.: 32 AF XY: 0.000659 AC XY: 49AN XY: 74348
GnomAD4 genome
AF:
AC:
107
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
49
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | May 12, 2023 | PVS1 PS3 - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 30, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 01, 2023 | The DOHH c.654_655insAACC p.(Glu219AsnfsTer54) variant causes a shift in the protein reading frame that is predicted to result in premature termination of the protein. Loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay is expected; however any truncated protein that is produced will lack the carboxy-terminal HEAT domains which are important for iron binding and enzyme activity (Kim et al 2006). This variant has been reported in trans with two different missense variants in patients from two unrelated families with neurodevelopmental abnormalities, one of whom was biochemically tested and found to have reduced DOHH protein level and enzyme activity (Ziegler et al 2022). In one of these families this variant segregated with disease in two siblings together with the other missense variant. Purified recombinant truncated protein resulting from this variant was found to have no enzymatic activity in-vitro (Ziegler et al 2022). The highest frequency of this allele in the Genome Aggregation Database is 0.001339 in the European (non-Finnish) population, with no homozygous individuals reported (version 3.1.2). Based on the available evidence, the c.654_655insAACC p.(Glu219AsnfsTer54) variant is classified as likely pathogenic for neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment. - |
DOHH related neurodevelopmental disorder Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Genetics, CHU d'Angers | Sep 22, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at